Pair Name | Plumbagin, rsTRAIL | ||
Phytochemical Name | Plumbagin (PubChem CID: 10205 ) | ||
Anticancer drug Name | rsTRAIL (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Plumbagin, rsTRAIL | |||
Disease Info | [ICD-11: 2B33.4] | Leukemia | Investigative | |
Biological Phenomena | Induction-->ROS generation | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BID | hsa637 | |
Up-regulation | Expression | CASP8 | hsa841 | |
Down-regulation | Expression | CFLAR | hsa8837 | |
Up-regulation | Expression | TNFRSF10B | hsa8795 | |
In Vitro Model | Kasumi-1 | Childhood acute myeloid leukemia with maturation | Homo sapiens (Human) | CVCL_0589 |
In Vivo Model | Kasumi-1 cells were injected s.c. into the flanks of the mice (2.5×10⁶ in 2 ml) and tumors were allowed to develop for 18–30 days until they reached 50–100 mm3, then treatment was initiated. | |||
Result | Our results suggest that both plumbagin and rsTRAIL could be used as a single agent or synergistical agents to induce apoptosis of leukemic Kasumi‑1 cells in vitro and in vivo. |
No. | Title | Href |
---|---|---|
1 | Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP. Oncol Rep. 2017;37(6):3423-3432. doi:10.3892/or.2017.5627 | Click |